JADO Technologies Appoints New CEO
2007-09-05
JADO Technologies, the leading developer of novel cell membrane-targeted drugs, today announced the appointment of Charl van Zyl as its new Chief Executive Officer. Charl van Zyl will take over from Dr. Gary Jennings, cofounder and former CEO/CSO, who will continue as Chief Scientific Officer.
适应症
-靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。